Immunoinflammatory mechanisms in lung cancer development: is leptin a mediator?

Ricardo Ribeiro; António Araújo; Carlos Lopes; Rui Medeiros

doi:10.1016/s1556-0864(15)30035-6

Immunoinflammatory mechanisms in lung cancer development: is leptin a mediator?

J Thorac Oncol. 2007 Feb;2(2):105-8. doi: 10.1016/s1556-0864(15)30035-6.

Authors

Ricardo Ribeiro¹, António Araújo, Carlos Lopes, Rui Medeiros

Affiliation

¹ Molecular Oncology--CI, Portuguese Institute of Oncology, Porto, Portugal.

PMID: 17410023
DOI: 10.1016/s1556-0864(15)30035-6

Abstract

This is a short review focusing on leptin immunoinflammatory mechanisms that ultimately may contribute to lung cancer development. We explored the complex and intricate interaction of leptin with immune cells to propose a pathway of inflammation-associated lung cancer development.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Humans
Immunity, Innate
Leptin / immunology*
Lung Neoplasms / immunology*

Substances

Leptin